Mechanistically, miR-145 disrupts TGF-β signaling cascades that usually promote M2 polarization, angiogenesis, and metastatic progression, while simultaneously inhibiting IGF1R-mediated survival and proliferation signals that support tumor-associated macrophage accumulation [111]. The gene discussed is TGFB1; the disease is neoplasm.